Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder

Abstract Background Amygdala subregion-based network dysfunction has been determined to be centrally implicated in major depressive disorder (MDD). Little is known about whether ketamine modulates amygdala subarea-related networks. We aimed to investigate the relationships between changes in the r...

Full description

Bibliographic Details
Published in:	European Psychiatry
Main Authors:	Haiyan Liu, Chengyu Wang, Xiaofeng Lan, Weicheng Li, Fan Zhang, Zhibo Hu, Yanxiang Ye, Yuping Ning, Yanling Zhou
Format:	Article
Language:	English
Published:	Cambridge University Press 2024-01-01
Subjects:	amygdala subregion antidepressant functional connectivity ketamine major depressive disorder
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933824017449/type/journal_article

Similar Items

Abnormal resting-state functional connectivity in subregions of amygdala in adults and adolescents with major depressive disorder
by: Lin Guan, et al.
Published: (2024-07-01)

Common and Specific Alterations of Amygdala Subregions in Major Depressive Disorder With and Without Anxiety: A Combined Structural and Resting-State Functional MRI Study
by: Yao Yao Li, et al.
Published: (2021-02-01)

Amygdala subregional functional connectivity in treatment-resistant depression
by: Sheryl L. Foster, et al.
Published: (2025-07-01)

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
by: Songbai Xu, et al.
Published: (2022-07-01)

The Ketamine Antidepressant Story: New Insights
by: Tahani K. Alshammari
Published: (2020-12-01)

Clinical research progress on the antidepressant effects of ketamine
by: Fan Ni
Published: (2021-06-01)

Selective disrupted gray matter volume covariance of amygdala subregions in schizophrenia
by: Zhongyu Chang, et al.
Published: (2024-04-01)

Ketamine and the potential role for rapid-acting antidepressant medications
by: JH Krystal
Published: (2007-04-01)

Resting-state functional connectivity of amygdala subregions across different symptom subtypes of obsessive–compulsive disorder patients
by: Harah Kwon, et al.
Published: (2024-01-01)

Sex differences in the effects of repeated ketamine infusions on bone markers in patients with unipolar and bipolar depression
by: Xiaofeng Lan, et al.
Published: (2024-01-01)

Altered volume of the amygdala subregions in patients with chronic low back pain
by: Si-Yu Gu, et al.
Published: (2024-03-01)

Ketamine: A New Antidepressant?
by: Feride Karacaer
Published: (2015-03-01)

From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression
by: Aleksandra Kupferberg, et al.
Published: (2024-10-01)

Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy
by: Sandra Ledesma-Corvi, et al.
Published: (2023-10-01)

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
by: Caroline Ann Browne, et al.
Published: (2013-12-01)

Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study
by: Naomichi Okamoto, et al.
Published: (2022-04-01)

Antidepressant Effect of Ketamine in Sub Anaesthetic Doses in Male Albino Mice
by: Lourdu Jafrin Antony, et al.
Published: (2014-06-01)

Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice
by: Gabriela N. Vaz, et al.
Published: (2024-12-01)

Rapid resolution of grief with IV infusion of ketamine: a unique phenomenological experience
by: Mahesh Ramanna Gowda, et al.
Published: (2016-01-01)

The volumes of amygdala subregions and peripheral programmed cell death protein‐1 levels are associated with cognitive decline in individuals with knee osteoarthritis
by: Peiling Zeng, et al.
Published: (2024-10-01)

Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine
by: Ming-Fen Ho, et al.
Published: (2019-11-01)

Beyond therapeutic potential: a systematic investigation of ketamine misuse in patients with depressive disorders
by: Keshav Juneja, et al.
Published: (2024-07-01)

Ketamine in the Treatment of Depression
by: Urszula Agnieszka Kaczmarska, et al.
Published: (2025-02-01)

Role of ketamine in treatment-resistant depression
by: Joanna Dmochowska, et al.
Published: (2025-04-01)

Antidepressant Low Doses of Ketamine and Melatonin in Combination Produce Additive Neurogenesis in Human Olfactory Neuronal Precursors
by: Rosa Estrada-Reyes, et al.
Published: (2022-09-01)

Recent Research Progress of the Mechanism of Adult-born Immature Granule Neurons Underlying Rapid Antidepressant Effect of Ketamine
by: WEI Sheng, et al.
Published: (2022-10-01)

Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
by: Adam Włodarczyk, et al.
Published: (2023-01-01)

Mania following ketamine abuse
by: Lu Y, et al.
Published: (2016-01-01)

Controversies of the effect of ketamine on cognition
by: Melvyn WB Zhang, et al.
Published: (2016-03-01)

Safety of Repeated Administration of Parenteral Ketamine for Depression
by: David Feifel, et al.
Published: (2020-07-01)

Design, Synthesis and Biological Evaluation of Novel Ketamine Derivatives as NMDAR Antagonists
by: Shiyun Li, et al.
Published: (2024-05-01)

Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
by: Hai-Xia Chang, et al.
Published: (2023-05-01)

Corrigendum: Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
by: Hai-Xia Chang, et al.
Published: (2023-06-01)

Subcutaneous Ketamine in Depression: A Systematic Review
by: Vitor Breseghello Cavenaghi, et al.
Published: (2021-05-01)

Editorial: Perspectives on new fast-acting antidepressants
by: Rodrigo Simonini Delfino, et al.
Published: (2024-05-01)

The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
by: Carlos A. Zarate Jr., et al.
Published: (2010-01-01)

A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine
by: Ola Sobhy A. Elmeseiny, et al.
Published: (2024-02-01)

Guidelines for ketamine use in clinical psychiatry practice
by: Luke A. Jelen, et al.
Published: (2024-05-01)

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression
by: August P. M. Lullau, et al.
Published: (2023-08-01)

Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications
by: Senbing Zhang, et al.
Published: (2024-04-01)